You are visiting a Fondation René Touraine website.    Donate English Français

Developing EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia

Wednesday 28 May 2014

Edimer Pharmaceuticals is dedicated to developing EDI200 as a treatment for X-linked Hypohidrotic Ectodermal Dysplasia (XLHED).
Learn more on Edimer website.

Fondation René Touraine